The Deal Sheet!

About the company

Hera Biotech, Inc. was formed to apply advances in biotechnology to address unmet needs in the field of women’s health and specifically, in reproductive medicine. Hera began operations in January of 2020 as a Delaware “C” Corporation with headquarters in San Antonio, TX. Hera’s initial goal is to commercialize the MetriDx™, a novel, non-surgical method for the definitive and early diagnosis of endometriosis..

Transaction Details

Investment Fund:
Birmingham Angels
$$ Committed:
Seed / Post Revenue
Convertible Note

Have a deal to pitch us?

Please apply here